In modern America, we are blessed to have easy access to a plethora of prescription drug options when we fall ill. These drugs and the positive impact they have on our health and well-being are nothing short of a minor miracle that has fundamentally altered our lives for the better.
Of course, for that statement to remain true it is imperative that our prescription drugs continue to be subject to rigorous oversight and testing. Side-effects are to be expected, but it is the job of the U.S. Food and Drug Administration (FDA) to ensure that the risk from whatever deleterious effects may be present is far outweighed by the potential for positive outcomes.
Unfortunately, generic prescription drug manufacturers (which make up roughly 80% of the drug marketplace) have been prevented from independently updating their labels to warn of newly discovered side-effects. This loophole prevents these companies from any liability or accountability if their drugs cause an adverse reaction that harms Americans.
Recognizing the importance of this issue, the FDA has moved swiftly to propose legislation that can close this loophole and provide peace of mind for consumers who rely on generic prescriptions. However, the generic drug industry is backed by powerful interests that have already delayed the passage of this legislation once and threaten to do so again without urgent action.
At Milestone, we take issues of public health and safety very seriously, and this legislation is no exception. We believe strongly that this loophole must be closed in as expedient of a manner as possible. To that end, we happily signed the below pledge on Change.org and encourage anyone reading this to do the same. Together, our actions can help impact this situation and guarantee a safer future for our families and communities.
The pledge, started by Take Justice Back (a wonderful organization focused on providing justice to all Americans), contains this letter:
U.S. Food and Drug Administration
We believe it is critically important that all prescription medicines, including generic drugs, carry current and accurate safety warnings. Both brand name and generic manufacturers should be accountable for the safety of their products.
We applaud the FDA for your proposal to fix the generic drug safety loophole, but we are concerned that the rule has been delayed. We urge you to finalize the generic drug labeling proposal as promptly as possible. Safety is an issue that cannot wait.”
For more information, or to sign the pledge, please visit this link today.
A West Point graduate where he served as captain and military aviator, John Bair continues his commitment to our country through his efforts within the settlement planning industry. He has represented families of victims lost in the Flight 3407 crash, offered pro bono services to the families of 9/11 victims and drafted the first consumer protection bill for plaintiffs (H.R. 3699).